|Articles|October 14, 2019
SEC-MALS Method for Characterizing mRNA Biophysical Attributes
Author(s)Wyatt
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
3
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
